Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial.
Saved in:
| Title: | Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial. |
|---|---|
| Authors: | Yuan, Yupei1 (AUTHOR), Luo, Shihong1 (AUTHOR), Wang, Xiaomin2 (AUTHOR), Zheng, Zhiyong2 (AUTHOR), Qi, Qing3 (AUTHOR), Wang, Yunxiao3 (AUTHOR), Chen, Meiling4 (AUTHOR), Yang, Haihua5 (AUTHOR), Gu, Pingjun5 (AUTHOR), Du, Qin6 (AUTHOR), Wu, Xia7 (AUTHOR), Pan, Wenyan8 (AUTHOR), Xu, Yuanji9 (AUTHOR), Wang, Jianyang1 (AUTHOR) pkucell@163.com |
| Source: | Radiation Oncology. 4/18/2025, Vol. 20 Issue 1, p1-6. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
